Integrin-Targeting Strategies for Adenovirus Gene Therapy
Viruses · 2024
DOI: 10.3390/v16050770 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, 2024. Verfasst von Glen R Nemerow. Beteiligte Einrichtung: Department of Immunology, The Scripps Research Institute, 10666 North Torrey Pines Rd, La Jolla, CA 92037, USA. Hauptthemen laut MEDLINE: Genetic Therapy, Integrins, Virus Internalization. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Numerous human adenovirus (AdV) types are endowed with arginine–glycine–aspartic acid (RGD) sequences that enable them to recognize vitronectin-binding (αv) integrins. These RGD-binding cell receptors mediate AdV entry into host cells, a crucial early step in virus infection. Integrin interactions with adenoviruses not only initiate receptor-mediated endocytosis but also facilitate AdV capsid disassembly, a prerequisite for membrane penetration by AdV protein VI. This review discusses fundamental aspects of AdV–host interactions mediated by integrins. Recent efforts to re-engineer AdV vectors and non-viral nanoparticles to target αv integrins for bioimaging and the eradication of cancer cells will also be discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, The Scripps Research Institute, 10666 North Torrey Pines Rd, La Jolla, CA 92037, USA.
ORCID-Profile: Glen R Nemerow
Zitieren
APA
Nemerow, G. R. (2024). Integrin-Targeting Strategies for Adenovirus Gene Therapy. Viruses. https://doi.org/10.3390/v16050770
Vancouver
Nemerow GR. Integrin-Targeting Strategies for Adenovirus Gene Therapy. Viruses. 2024. doi:10.3390/v16050770
BibTeX
@article{Nemerow2024,
author = {Nemerow, Glen R},
title = {Integrin-Targeting Strategies for Adenovirus Gene Therapy},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16050770}
}
EUVIMED